爱尔兰爵士制药去纤苷售价多少？

(Defibrotide) was first developed by Gentium Pharmaceuticals in Italy and was approved for marketing in the EU in October 2013. After Gentium Pharmaceuticals was acquired by American Jazz Pharmaceuticals, Defibrotide sodium was approved by the U.S. Food and Drug Administration (FDA) to be launched in the United States on March 30, 2016, under the trade name Defitelio. So, how much does Irish Jazz Pharmaceuticals Defibrotide cost?

It is understood that the price of Defibrotide, a drug owned by Irish Jazz Pharmaceuticals, is around $22,000, and the specification is 200mg. Since this drug has not yet been approved for marketing in China, it is currently unavailable to patients in China. However, patients can obtain their drug purchase channels through reliable overseas medical service organizations in China (such as Medical Companion Travel). For patients, it is particularly necessary to grasp the timing of treatment, otherwise the condition may worsen.

Jazz Pharmaceuticals was founded in 2003 and is headquartered in Dublin, Ireland, with 885 full-time employees. It is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of pharmaceutical products. Since its founding in 2003, it has built a commercial and development organization and assembled products and product candidates that currently include two commercially available products, as well as product candidates in various stages of clinical development. At present, defibrotide has been owned by Irish Jazz Pharmaceuticals. The successful launch of the drug has also caused a huge response in the industry and is worthy of the trust of patients.

Defibrinoside from Sir Irish Pharmaceuticals is an oligonucleotide that can regulate platelet activity, inhibit thrombin release and activity, downregulate PAI-1 levels, have local anti-thrombosis and anti-inflammatory effects, promote fibrinolysis, and selectively act on small blood vessels. The treatment of hepatic veno-occlusive disease (HVOD) is effective and has few adverse drug reactions, and has become a research hotspot in recent years.

Recommended hot articles/newsDetail/86996.html